The goal of this eHealth Source™ activity is to educate clinicians on atopic dermatitis pathoetiology, best practices in patient evaluations, and the clinical profiles of treatment options for moderate-to-severe disease, including a biologic therapy recently approved by the US Food and Drug Administration (FDA). With the overall goal of improving outcomes for patients with moderate-to-severe atopic dermatitis, this educational activity integrates published clinical data and the experience of expert faculty to provide actionable recommendations on individualizing care and improving patient-clinician communication.
The goal of this eHealth Source™ activity is to educate clinicians on atopic dermatitis pathoetiology, best practices in patient evaluations, and the clinical profiles of treatment options for moderate-to-severe disease, including a biologic therapy recently approved by the US Food and Drug Administration (FDA). With the overall goal of improving outcomes for patients with moderate-to-severe atopic dermatitis, this educational activity integrates published clinical data and the experience of expert faculty to provide actionable recommendations on individualizing care and improving patient-clinician communication.
Atopic Dermatitis: New Perspectives on Managing a Chronic Inflammatory Disease
50
Atopic Dermatitis: New Perspectives on Managing a Chronic Inflammatory Disease
50
Product Details
| ISBN-13: | 9780998419411 |
|---|---|
| Publisher: | Integritas Communications |
| Publication date: | 02/23/2018 |
| Sold by: | PUBLISHDRIVE KFT |
| Format: | eBook |
| Pages: | 50 |
| File size: | 2 MB |